Interestingly, two of the analytes (80.1-4 and 42.3-13) were found in the groups of peaks discriminating between idiopathic and LRRK2 PD patients and between asymptomatic LRRK2 mutation carriers and controls. The gene discussed is LRRK2; the disease is Parkinson disease.